BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹153 Cr |
Mar2024 | ₹148 Cr |
Mar2023 | ₹130 Cr |
Mar2022 | ₹90 Cr |
Mar2021 | ₹86 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹153 Cr | 3.65 | |
Mar2024 | ₹148 Cr | 13.97 | |
Mar2023 | ₹130 Cr | 43.75 | |
Mar2022 | ₹90 Cr | 4.25 | |
Mar2021 | ₹86 Cr | - |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹310.1 Cr | 10.8% | 18.7% | 44.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,996.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 10.8% |
18.7% |
44.9% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses